These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 2249378

  • 1. Combined alpha/beta-blockade versus beta 1-selective blockade in essential hypertension in black and white patients.
    Townsend RR, DiPette DJ, Goodman R, Blumfield D, Cronin R, Gradman A, Katz LA, McCarthy EP, Sopko G.
    Clin Pharmacol Ther; 1990 Dec; 48(6):665-75. PubMed ID: 2249378
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The effectiveness of labetalol compared to hydrochlorothiazide in hypertensive black patients.
    Lucas C, Jenkins P, Mendels J, Due D, Forbes WP, Sirgo MA.
    J Natl Med Assoc; 1991 Oct; 83(10):866-71. PubMed ID: 1800760
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Multiclinic comparison of labetalol to metoprolol in treatment of mild to moderate systemic hypertension.
    Frishman WH, Michelson EL, Johnson BF, Poland MP.
    Am J Med; 1983 Oct 17; 75(4A):54-67. PubMed ID: 6356900
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Comparative effects of an alpha 1 and beta 1-2 blocker (labetalol) and a beta-1 blocker (atenolol) in the hypertensive patient].
    Sassard J, Zech PY, Pozet N, Cuisinaud G, Vincent M.
    J Pharmacol; 1983 Oct 17; 14 Suppl 2():121-9. PubMed ID: 6355664
    [Abstract] [Full Text] [Related]

  • 10. Monotherapy with labetalol in the treatment of mild hypertension: a double-blind study.
    Davidov ME, Moir GD, Poland MP, Maloy J, Medakovic M.
    Am J Med; 1983 Oct 17; 75(4A):47-53. PubMed ID: 6356899
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Dose-response evaluation of oral labetalol in patients presenting to the emergency department with accelerated hypertension.
    Gonzalez ER, Peterson MA, Racht EM, Ornato JP, Due DL.
    Ann Emerg Med; 1991 Apr 17; 20(4):333-8. PubMed ID: 2003657
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Haemodynamic effects of atenolol, labetalol, pindolol and captopril: a comparison in hypertensive patients with special reference to changes in limb blood flow, heart rate and left ventricular function.
    Roberts DH, Tsao Y, Grimmer SF, Winstanley PA, Orme ML, Breckenridge AM.
    Br J Clin Pharmacol; 1987 Aug 17; 24(2):163-72. PubMed ID: 2887190
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparison of a new vasodilating beta-blocker, carvedilol, with atenolol in the treatment of mild to moderate essential hypertension.
    Ruilope LM.
    Am J Hypertens; 1994 Feb 17; 7(2):129-36. PubMed ID: 7910028
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A comparative study on the effect of atenolol and labetalol on exercise capacity and lipid serum levels in essential hypertension.
    Schamaun O, Westheim A, Qvigstad EK, Teisberg P.
    Nephron; 1987 Feb 17; 47 Suppl 1():135-7. PubMed ID: 3320787
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.